PMV Pharmaceuticals PMVP Insider Ownership

NASDAQ PMVP
$1.43 +0.07 (+5.15%)
At close: Sep 29, 2026 · 4:00 PM EDT

Insider Holdings by Owner

6.83Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026
Insider Ownership
13.11%
▼-9.20% pp QoQ
Shares Held by Insiders
7.00Mn
filed for Sep 2026
▼-41.24% QoQ
Shares Outstanding
53.39Mn
53,386,909 shares
Direct Holdings
756.42K
Indirect: 6.24Mn
Net Shares Traded (QoQ)
-4.91Mn
net selling in Sep 2026
Insiders Holding Shares
8
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest —
Average ownership —
Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold
Latest quarter —
Net over range —
Buying quarters —

Insider Ownership Summary

Quarter ending 30 Sep, 2026

PMVP's three largest insider shareholders as of September 29, 2026 are Advisors Llc Orbimed (TenPercentOwner, 4.98Mn shares), Thilo Schroeder (Director, 1.10Mn shares), David Henry Mack (President And Ceo, 451.11K shares).

Form 4 Holdings

Insiders Holding PMVP

Insiders 8
Shares held 6.83Mn
Of outstanding 12.80%
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Advisors Llc Orbimed TenPercentOwner 0 4,975,291 4,975,291 72.8% 27 Oct, 2025
2 Thilo Schroeder Director 0 1,101,283 1,101,283 16.1% 08 Oct, 2021
3 David Henry Mack President And Ceo 451,109 0 451,109 6.6% 29 Oct, 2025
4 Robert Ticktin General Counsel Coo 98,695 0 98,695 1.4% 03 Jul, 2025
5 Deepika Jalota Chief Development Officer 89,959 0 89,959 1.3% 03 Jul, 2025
6 Michael Carulli Chief Financial Officer 60,146 0 60,146 0.9% 03 Jul, 2025
7 Leila Alland Chief Medical Officer 45,909 0 45,909 0.7% 18 Sep, 2023
8 Winston Kung Coo, Cfo 10,600 0 10,600 0.2% 30 Jan, 2022

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

456 Insider Transactions

Source SEC Form 4
Latest quarter Sep 2026
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
04 Jun, 2026 Laurie Stelzer Director Acquired A 42,000 $0.00 $0 42,000 Direct
04 Jun, 2026 Kirsten Flowers Director Acquired A 42,000 $0.00 $0 42,000 Direct
04 Jun, 2026 Arnold J Levine Director Acquired A 42,000 $0.00 $0 42,000 Direct
04 Jun, 2026 Charles M Baum Director Acquired A 42,000 $0.00 $0 42,000 Direct
04 Jun, 2026 Carol Giltner Gallagher Director Acquired A 42,000 $0.00 $0 42,000 Direct
04 Jun, 2026 Carol Giltner Gallagher Director Disposed G 42,000 $0.00 $0 0 Direct
04 Jun, 2026 Carol Giltner Gallagher Director Acquired G 42,000 $0.00 $0 42,000 Indirect
05 Mar, 2026 Robert Ticktin General Counsel Coo Acquired A 319,270 $0.00 $0 319,270 Direct
05 Mar, 2026 David Henry Mack President And Ceo Acquired A 744,960 $0.00 $0 744,960 Direct
05 Mar, 2026 Deepika Jalota Chief Development Officer Acquired A 303,310 $0.00 $0 303,310 Direct
05 Mar, 2026 Michael Carulli Chief Financial Officer Acquired A 240,000 $0.00 $0 240,000 Direct
27 Oct, 2025 David Henry Mack President And Ceo Acquired M 220,643 $1.37 $302.28K 451,109 Direct
27 Oct, 2025 David Henry Mack President And Ceo Disposed M 220,643 $0.00 $0 0 Direct
23 Oct, 2025 Advisors Llc Orbimed TenPercentOwner Disposed S 1,000,000 $1.52 $1.52Mn 4,975,291 Indirect
10 Sep, 2025 Advisors Llc Orbimed TenPercentOwner Disposed S 500,000 $1.80 $900.00K 5,975,291 Indirect
01 Jul, 2025 Robert Ticktin General Counsel Coo Disposed S 23,151 $1.06 $24.65K 98,695 Direct
01 Jul, 2025 Michael Carulli Chief Financial Officer Disposed S 28,249 $1.06 $30.08K 60,146 Direct
01 Jul, 2025 Deepika Jalota Chief Development Officer Disposed S 33,065 $1.06 $35.20K 89,959 Direct
01 Jul, 2025 David Henry Mack President And Ceo Disposed S 58,411 $1.06 $62.18K 536,133 Direct
05 Jun, 2025 Arnold J Levine Director Acquired A 33,500 $0.00 $0 33,500 Direct